Atlas Trials

Sunitinib and Capecitabine for First Line Colon Cancer

Clinical trial NCT00961571 · TERMINATED

Trial details

NCT number
NCT00961571
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2009-08-01
Primary completion
2011-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.